Analysis: Allergan is a $63B Botox job for AbbVie

Daily Herald | Business

Jun 25, 2019

When the maker of the top-selling arthritis drug says it's buying a leader in anti-wrinkle treatments, you'd be forgiven if your initial response to the news was that it seems like…